News & Events

Rob Etherington

21 October 2021

Search for:

Recent Posts

Sydney Neuroimaging Analysis Centre announces TGA (Class 2) approval of our flagship medical imaging-AI product, iQ- solutions
Sydney Neuroimaging Analysis Centre Receives Prestigious ANDHealth+ Program Funding
SNAC’S AI-BASED SOLUTION FOR MONITORING MULTIPLE SCLEROSIS VALIDATED IN REAL-WORLD MRI COHORT
MSBase Imaging Repository – Fully Integrated with SNAC’S iQ-Solutions
Exciting news! Our Co-founder and Chief Operating Officer, Chenyu Wang, was recently invited to speak at NVIDIA’s GTC23 about the latest advances in federated learning for medical imaging applications.

The collaboration between SynergyRadiology and SNAC puts us at the forefrontof artificial intelligence developments in thefield, with smart worklists, improved radiologistproductivity and enhanced reporting for ourpatients and referring clinicians.

— Prashant Menon , Country Head , Qualitas Healthcare Australia

The abundance of data produced by state-of-the-art scanners provides us with an opportunity to extract unprecedented detail from brain and body images. This is where automation and AI will add tremendous value to radiology–we look forward to working closely with the SNAC team.

— Dr Eugene Hsu , Radiologist , St Vincent's Hospital, Sydney

Sydney Neuroimaging Analysis Center (SNAC) has been an extraordinary partner in our clinical plans for our lead asset. When we considered Australia for our clinical trial work in neurodegenerative disease, it was quickly apparent that SNAC was the right partner. We’ve been incredibly grateful for the support we’ve received from every team member at SNAC; the SNAC team members consistently provide a level of professionalism and solid collaboration in the rigorous clinical framework required for pharmaceutical clinical drug development. Clene looks forward to further partnership with SNAC.

— Rob Etherington , President & CEO , Clene Nanomedicine

Trusted Partners